ClinicalTrials.Veeva

Menu
H

Hull University Teaching Hospitals NHS Trust | Hull Royal Infirmary - Academic Renal Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Risankizumab
Remdesivir
Niclosamide
BZF
Paclitaxel
Veliparib
Ranibizumab
ABT-888
BOTOX
Guselkumab

Parent organization

This site is a part of Hull University Teaching Hospitals NHS Trust

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 37 total trials

A Multicentre European Study to Evaluate Granulox® Used in the Treatment Pathway of Predominantly Chronic Venous Leg Ulcers (VLUs). (Granulox01)

The investigation is designed as an open label, randomized, prospective, assessor blinded, multi centre investigation.254 evaluable subjects will be...

Active, not recruiting
Venous Leg Ulcer
Device: Venous Leg Ulcer Standard of Care with Granulox

The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety o...

Enrolling
Perianal Crohns Disease
Fistulizing Crohns Disease
Drug: Guselkumab
Drug: Placebo

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Study WR42221 is a Phase IIIb, global, multicenter, randomized, visual assessor-masked study designed to assess the efficacy, safety, and pharmacokin...

Enrolling
Neovascular Age-related Macular Degeneration (nAMD)
Device: Port Delivery System with Ranibizumab
Drug: Ranibizumab

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN281...

Enrolling
Melanoma
Drug: Cemiplimab
Drug: Placebo

The aim of the study is to compare performance and safety of a newly developed 14-gauge open-tip pulsed biopsy needle with a conventional 14-gauge co...

Enrolling
Breast Cancer
Device: Open-tip pulsed needle biopsy (NeoNavia Biopsy System)
Device: Core needle biopsy (CNB)

COVID-19 (SARS-CoV2 virus) was declared a global pandemic by the WHO on 11th March 2020. Currently there are no drugs proven to prevent COVID-19 or t...

Enrolling
Covid19
Drug: Placebo
Drug: Sotrovimab

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Enrolling
Primary Biliary Cirrhosis
Drug: Seladelpar 5 mg Capsule
Drug: Seladelpar 10 mg Capsule

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: Placebo
Drug: BOTOX

Study to evaluate the efficacy, safety, and tolerability of investigational drug obeticholic acid (OCA) in combination with the investigational drug...

Active, not recruiting
Primary Biliary Cholangitis
Drug: Bezafibrate 400 mg Placebo
Drug: Bezafibrate 200 MG

The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target...

Enrolling
Crohn Disease
Diagnostic Test: MRE

Trial sponsors

AbbVie logo
NHS Trust logo
E
Gilead Sciences logo
Roche logo
U
CymaBay Therapeutics logo
G
G
Imperial College London logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems